Filters close
27-Mar-2024 3:05 PM EDT
Study provides a first look at oncologists' views on ethical implications of AI in cancer care
Dana-Farber Cancer Institute

In a survey of more than 200 U.S. oncologists, vast majority indicate that oncologists should be able to explain how AI works to their patients. Respondents say AI developers, more than oncologists or hospitals, have responsibility for legal issues arising from AI use in cancer care.

Released: 28-Mar-2024 9:35 AM EDT
Serum Detect Launches with Novel T-Cell Analysis Approach for Cancer Early Detection at AACR
Serum Detect Inc.

The new company, led by a former executive from Foundation Medicine and Gritstone bio, is using advances in T-cell receptor repertoire analysis to reveal previously undetectable signals in standard liquid biopsy samples.

Newswise: Andrew E. Place, MD, PhD appointed as Dana-Farber/Boston Children’s Cancer and Blood Disorders Center Vice President, Pediatric Chief Medical Officer
Released: 28-Mar-2024 9:00 AM EDT
Andrew E. Place, MD, PhD appointed as Dana-Farber/Boston Children’s Cancer and Blood Disorders Center Vice President, Pediatric Chief Medical Officer
Dana-Farber Cancer Institute

Andrew E. Place, MD, PhD, has been named as Vice President, Pediatric Chief Medical Officer (CMO) at Dana-Farber Cancer Institute (within the Department of Pediatric Oncology) and Boston Children’s Hospital (within the Division of Hematology/Oncology) for the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.

Released: 28-Mar-2024 8:05 AM EDT
Aster Insights Announces AACR Schedule of ORIEN Presentations
Aster Insights

Aster Insights, the leading provider of scientific and clinical intelligence for oncology discovery, today announced its schedule of research presentations at the American Association for Cancer Research (AACR) annual meeting in San Diego, California, April 5-10, 2024.

access_time Embargo lifts in 2 days
Embargo will expire: 28-Mar-2024 2:00 PM EDT Released to reporters: 27-Mar-2024 7:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 28-Mar-2024 2:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

   
Newswise: 1920_active-surveillance-cancer-cedars-sinai.jpg?10000
Released: 27-Mar-2024 3:05 PM EDT
RESEARCH ALERT: Malpractice Trends Involving Active Surveillance Across Cancers
Cedars-Sinai

In a new study, Cedars-Sinai Cancer investigators explored malpractice trends related to active surveillance as a treatment strategy across cancers. They found that to date, there has been no successful litigation related to active surveillance.

Newswise: Combining Epigenetic Cancer Medications May Have Benefit for Colorectal Cancers and Other Tumor Types
27-Mar-2024 1:30 PM EDT
Combining Epigenetic Cancer Medications May Have Benefit for Colorectal Cancers and Other Tumor Types
Van Andel Institute

A pair of medications that make malignant cells act as if they have a virus could hold new promise for treating colorectal cancers and other solid tumors, reports a study published today in Science Advances.

Released: 27-Mar-2024 1:05 PM EDT
HERSTORY: Democratizing cancer genetic testing to reduce healthcare disparities
University of California, Los Angeles (UCLA), Health Sciences

HERSTORY is focused on understanding genetic, environmental, socio-economic, and other determinants of cancer in women with a family history of the disease.

Newswise: Researchers turn back the clock on cancer cells to offer new treatment paradigm
Released: 27-Mar-2024 12:05 PM EDT
Researchers turn back the clock on cancer cells to offer new treatment paradigm
St. Jude Children's Research Hospital

St. Jude Children’s Research Hospital scientists reversed an aggressive cancer, reverting malignant cells towards a more normal state.

Newswise: Palliative care leader receives prestigious ASCO Special Award
Released: 27-Mar-2024 10:05 AM EDT
Palliative care leader receives prestigious ASCO Special Award
Dana-Farber Cancer Institute

The American Society of Clinical Oncology (ASCO) recognized Janet L. Abrahm, MD, FACP, FAAHPM, of Dana-Farber Cancer Institute and Brigham and Women’s Hospital, as a recipient of an ASCO Special Award, the Society’s highest honor.

Newswise: Experts Highlight Strategies for Cancer Control and Prevention
Released: 27-Mar-2024 9:05 AM EDT
Experts Highlight Strategies for Cancer Control and Prevention
Rutgers Cancer Institute of New Jersey

Many cancers can be prevented, and others can be detected early in their development, treated and cured.

Newswise: Empowering Minority Cancer Patients: Tips for Advocacy and Support
Released: 27-Mar-2024 9:05 AM EDT
Empowering Minority Cancer Patients: Tips for Advocacy and Support
Rutgers Cancer Institute of New Jersey

Mariam F. Eskander, MD, MPH, surgical oncologist in the Gastrointestinal Oncology Program at Rutgers Institute of New Jersey, offers insight and tips for minority individuals navigating a cancer diagnosis and how we can all work together to mitigate cancer disparities.

Newswise: Testicular Cancer: Expert Advice for Early Detection
Released: 27-Mar-2024 9:05 AM EDT
Testicular Cancer: Expert Advice for Early Detection
Rutgers Cancer Institute of New Jersey

Vignesh T. Packiam, MD, director of Clinical and Translational Research in Urologic Oncology and a urologic oncologist in the Urologic Oncology Program at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, the state’s leading cancer program and only NCI-designated Comprehensive Cancer Center, shares about testicular cancer and what men should know.

Newswise: 10 Facts about Head & Neck Cancers
Released: 27-Mar-2024 9:05 AM EDT
10 Facts about Head & Neck Cancers
Rutgers Cancer Institute of New Jersey

Head and neck cancer is the term used to describe a number of different malignant tumors that develop in or around the throat, larynx, nose, sinuses and mouth.

Newswise: Answers from an Expert: Esophageal Cancer
Released: 27-Mar-2024 9:05 AM EDT
Answers from an Expert: Esophageal Cancer
Rutgers Cancer Institute of New Jersey

Benjamin Medina, MD, thoracic surgeon in the Lung/Thoracic Oncology Program at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, answers common questions about esophageal cancer during esophageal cancer awareness month.

Newswise: New Genetic Analysis Tool Tracks Risks Tied to CRISPR Edits
Released: 26-Mar-2024 6:05 PM EDT
New Genetic Analysis Tool Tracks Risks Tied to CRISPR Edits
University of California San Diego

While CRISPR has shown immense promise as a next-generation therapeutic tool, the gene editing technology’s edits are still imperfect. Researchers have developed a new system to test and analyze CRISPR-based DNA repair and related risks from unintended but harmful “bystander” edits.

Newswise: Researcher’s microscale tech is chipping away at cancer, organ failure and neurological disease
Released: 26-Mar-2024 3:05 PM EDT
Researcher’s microscale tech is chipping away at cancer, organ failure and neurological disease
Arizona State University (ASU)

For outstanding contributions to engineering of biomimetic tissue-on-chip technologies and organoids for disease modeling and regenerative medicine, ASU's Mehdi Nikkhah has been inducted as a Fellow into the American Institute for Medical and Biomedical Engineering.

Newswise:Video Embedded musicians-colbie-caillat-lisa-loeb-rufus-wainwright-hilary-hahn-and-more-support-colorectal-cancer-awareness-in-free-webcast-concert
VIDEO
Released: 26-Mar-2024 3:00 PM EDT
Musicians Colbie Caillat, Lisa Loeb, Rufus Wainwright, Hilary Hahn, and More Support Colorectal Cancer Awareness in Free Webcast Concert
American College of Gastroenterology (ACG)

The American College of Gastroenterology Free Virtual Event on March 28, 2024, at 8:00 pm ET, “Tune It Up: A Concert To Raise Colorectal Cancer Awareness”

Released: 26-Mar-2024 10:05 AM EDT
Genetically engineered dendritic cells enhance the power of immunotherapy against lung cancer
University of California, Los Angeles (UCLA), Health Sciences

The results of a UCLA study suggest that using CXCL9 and CXCL10-producing dendritic cells alongside immunotherapy can be a promising strategy to overcome treatment resistance and improve clinical outcomes for patients with non-small cell lung cancer.


Showing results

120 of 24566

close
3.68629